Company: APXT
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001213900-25-097069
Chunk: 377

Company: Apex Treasury Corp
Filing Date: 2025-10-07
Form: S-1/A
Chunk 377
---
 and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account, and have agreed to waive any right, title, interest or claim of any kind they may have in the future as a result of, or arising out of, any services provided to us and will not seek recourse against the trust account for any reason whatsoever (except to the extent they are entitled to funds from the trust account due to their ownership of public shares). Accordingly, any indemnification provided will only be able to be satisfied by us if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. Item 15. Recent Sales of Unregistered Securities. On June 30, 2025, Apex Treasury Sponsor LLC, our sponsor, paid $25,000, or approximately $0.003 per share, to cover certain of our offering costs in exchange for 9,583,333 Class B ordinary shares. In July 2025, our sponsor transferred 30,000 Class B ordinary shares to each of our independent director nominees (for an aggregate of 90,000 Class B ordinary shares), 50,000 Class B ordinary shares to each of our advisors (for an aggregate of 150,000 Class B ordinary shares) and 100,000 Class B ordinary shares to our Chief Financial Officer at the same per -shareprice that our sponsor purchased such shares, or approximately $0.003 per share, resulting in our sponsor holding 9,243,333 Class B ordinary shares. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 28,750,000 units if the underwriters’ over -allotmentoption is exercised in full and therefore that such founder shares would represent 25% of the outstanding shares after this offering. Up to 1,250,000 of these shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentis exercised.